- Home
- Applications
- USA
- oncology
Refine by
Oncology Product Applications Available In In Usa
29 applications found
4 Ways Digital Can Transform Treatment Selection in Oncology Expert insights on the challenges care teams face in pairing patients with oncology treatments and how digital health solutions can help New and innovative cancer treatments are coming to market faster than ever—a huge win for both patients and care teams. ...
ByBrightInsight, Inc based in San Jose, CALIFORNIA (USA)
Sinus, Nasal, Maxillo-Facial, Mandibular, Aural, Brain, Trauma, Oncology, Neuro Angiography with SeeFactor ...
ByEpica Human Health based in Duncan, SOUTH DAKOTA (USA)
AlNovo is pioneering new therapeutic modalities based on our Novobinder Platform to harness the power of the human immune system to directly attack cancer ...
ByAinovo Biotech Inc. based in Sacramento, CALIFORNIA (USA)
Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology to early detection and accurate prognosis. The greater therapeutic index of encapsulated paclitaxel, cisplatin and mitoxantrone among other chemotherapy drugs over their equivalent clinical counterparts has been proved multiple ...
ByNanovex Biotechnologies based in Llanera, SPAIN
We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
All areas of hospitals and medical specialties can benefit for the use of 99T’s systems, from surgery rooms to transplants units, from patients rooms to surgical theaters, from dialysis centers to oncology wards, from common areas to public ...
By99 Technologies S.A. based in Lugano, SWITZERLAND
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Prancer RTSM? enables you to follow the science. Whether you have a simple, first-in-human study or complex dose escalation trials, our RTSM solutions provide the flexibility to adapt and scale alongside your Phase 1 trials. ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
Simplifying The Complexities of Modern Health ...
ByNantHealth, Inc. based in Morrisville, NORTH CAROLINA (USA)
For the world’s leading radiation oncologists, cancer treatment has changed dramatically in recent years. Electron beam technology is becoming more precise, more portable and more efficient. And the interaction and collaboration with surgical teams in the OR has meant that radiation treatment has entered a new era. An era where the procedure is successfully administered in ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
ByKiadis Pharma NV based in Amsterdam, NETHERLANDS
Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...
ByinDNA Research Labs based in , INDIA
All your data in one place. Athelas delivers patient vitals into 80+ EHRs including Epic, Cerner and Athena. Seamlessly integrate RPM datapoints into your existing protocols for patient care and maximize clinical ...
ByAthelas Incorporated based in Mountain View, CALIFORNIA (USA)
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
The IntraOp® Mobetron® is the most comprehensive electron therapy linear accelerator system with applications in intraoperative radiotherapy (IORT) and non-invasive treatment of skin cancer. Now Mobetron is the first to offer ultra-high dose rate electron therapy for preclinical and investigational studies of FLASH radiotherapy on an established clinical radiotherapy platform. IntraOp’s advanced technology ushers in a new paradigm for cancer treatment by providing researchers an approach not possible ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
IntraOp® Mobetron® saves time and enables more treatments in the operating room. It increases productivity and enhances collaboration among surgical and radiation oncologists. Breast cancer treatment with IORT is precise and flexible. The patient experience and outcomes are better. The data is conclusive and ASTRO ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
The reputation of your cancer treatment facility hinges on your ability to recruit world-class oncologists. Those who can collaborate to leverage pioneering technologies and therapies for the benefit of their patients. It’s an investment in talent and technology. And your technology must be proven, precise and ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
You likely already know that electron-beam IORT has been successfully treating multiple cancer indications for nearly 50 years and has been treating breast cancer since the early 1990’s. The first accelerated partial breast irradiation (APBI) treatment with the IntraOp® Mobetron® was performed in 2006. Today, more than 20,000 women have been treated with electron IORT demonstrating equivalency in local control with reduced toxicity and improved cosmesis. More than 10,000 breast cancer patients have ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)